Analysts predict that Medidata Solutions Inc (NASDAQ:MDSO) will announce earnings per share of $0.39 for the current quarter, according to Zacks Investment Research. Eight analysts have provided estimates for Medidata Solutions’ earnings, with the highest EPS estimate coming in at $0.42 and the lowest estimate coming in at $0.36. Medidata Solutions reported earnings per share of $0.43 in the same quarter last year, which suggests a negative year over year growth rate of 9.3%. The company is scheduled to issue its next quarterly earnings results on Tuesday, July 23rd.
According to Zacks, analysts expect that Medidata Solutions will report full year earnings of $1.83 per share for the current financial year, with EPS estimates ranging from $1.77 to $1.88. For the next fiscal year, analysts forecast that the business will report earnings of $2.13 per share, with EPS estimates ranging from $2.00 to $2.27. Zacks’ EPS averages are a mean average based on a survey of sell-side research firms that that provide coverage for Medidata Solutions.
Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings data on Tuesday, April 30th. The company reported $0.45 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.12 by $0.33. Medidata Solutions had a return on equity of 9.28% and a net margin of 7.99%. The firm had revenue of $173.50 million for the quarter, compared to analyst estimates of $172.12 million. During the same quarter in the prior year, the company posted $0.40 earnings per share. Medidata Solutions’s quarterly revenue was up 16.3% on a year-over-year basis.
In other Medidata Solutions news, Director Robert Taylor sold 3,294 shares of the business’s stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $90.88, for a total transaction of $299,358.72. Following the sale, the director now directly owns 41,757 shares in the company, valued at $3,794,876.16. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 4.70% of the stock is currently owned by insiders.
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Securian Asset Management Inc boosted its position in Medidata Solutions by 1.5% during the first quarter. Securian Asset Management Inc now owns 7,587 shares of the company’s stock worth $556,000 after purchasing an additional 113 shares in the last quarter. Zions Bancorporation N.A. lifted its position in shares of Medidata Solutions by 5.9% in the second quarter. Zions Bancorporation N.A. now owns 3,521 shares of the company’s stock valued at $319,000 after acquiring an additional 195 shares in the last quarter. Stephens Inc. AR lifted its position in shares of Medidata Solutions by 8.7% in the fourth quarter. Stephens Inc. AR now owns 2,722 shares of the company’s stock valued at $184,000 after acquiring an additional 218 shares in the last quarter. Front Row Advisors LLC lifted its position in shares of Medidata Solutions by 1.7% in the fourth quarter. Front Row Advisors LLC now owns 13,043 shares of the company’s stock valued at $879,000 after acquiring an additional 220 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its position in shares of Medidata Solutions by 2.2% in the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 10,971 shares of the company’s stock valued at $804,000 after acquiring an additional 234 shares in the last quarter.
MDSO stock traded up $0.05 on Thursday, reaching $90.95. 39,021 shares of the company’s stock were exchanged, compared to its average volume of 1,025,082. The company has a fifty day moving average of $91.09. Medidata Solutions has a twelve month low of $60.10 and a twelve month high of $98.60. The company has a market cap of $5.65 billion, a price-to-earnings ratio of 94.75, a PEG ratio of 7.48 and a beta of 1.22. The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.57 and a current ratio of 2.57.
About Medidata Solutions
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.
Further Reading: What is channel trading?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.